Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/12/2018
SIETES contiene 92610 citas

 
 
 1 a 10 de 10 
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
Yancy CW. Sodium restriction in heart failure: too much uncertainty — Do the trials. JAMA Intern Med 2018:5 de noviembre. [Ref.ID 102849]
2.Enlace a cita original Cita con resumen
Yancy CW, Jessup M, Chair V, Bozkurt B, Butler J, Casey Jr DE, Colvin MM, Drazner MH, Filippatos G, Fonarow GC, Givertz MM, Hollenberg SM, Lundenfeld JA, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westake C. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure . Circulation 2016:1-46. [Ref.ID 100318]
3.Enlace a cita original
January CT, Wann LS, Alpert JS, Calkins H, Cleveland JC Jr, Cigarroa JE, Conti JB, Ellinior PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW. 2014 AHA/ACC/HRS guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Hearth Rhythm Society. Circulation 2014;129:1-107. [Ref.ID 97600]
4.
January CT, Wan SL, Alpert JS, Calkins H, Cleveland JC, Cigarroa JE, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW. 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and Heart Rhythm Society. Circulation 2014;130:e199-267. [Ref.ID 97389]
5. Cita con resumen
Hernández AF, Greiner MA, Fonarow GC, Hammill BG, Heidenreich PA, Yancy CW, Peterson EC, Curtis LH. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA 2010;303:1716-22. [Ref.ID 88364]
6. Cita con resumen
Albert NM, Yancy CW, Liang L, Zhao X, Hernández AF, Peterson ED, Cannon CP, Fonarow GC. Use of aldosterone antagonists in heart failure. JAMA 2009;302:1658-65. [Ref.ID 86979]
7. Cita con resumen
Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Pieper K, Sun JL, Yancy CW, Young JB, for the OPTIMIZE-HF Investigators and Hospitals. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes. Findings from OPTIMIZE-HF. Arch Intern Med 2008;168:847-54. [Ref.ID 82771]
9.Tiene citas relacionadas
10.Tiene citas relacionadas Cita con resumen
Yancy CW, Fowler MB, Colucci WS, Gilbert EM, Bristow M R, Cohn JN, Lukas MA, Young ST, Packer M, for the U.S. Carvedilol Heart Failure Study Group. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med 2001;344:1358-65. [Ref.ID 56295]
Seleccionar todas
 
 1 a 10 de 10